Tag: glioblastoma

January 16, 2019

Kazia Ready to Release Results from Ongoing Trials in 2019

Dr. James Garner, CEO of Kazia Therapeutics, shares updates on his company’s finances, pipeline, upcoming data readouts and manufacturing.
June 21, 2018

Inovio Doses First Patient in Phase 1/2 Study for Glioblastoma

Roughly 50 newly diagnosed GBM patients will participate in the open-label trial. The study began on May 31, 2018 is...